Get started
Author

Paul Minnis

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39
PDF
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
2024 · Giles Dixon, Samuel Hague, et al. · ERJ Open Research · 27
PDF
Adalimumab for refractory pulmonary sarcoidosis
2015 · P. A. Minnis, M. Poland, et al. · Irish Journal of Medical Science (1971 -) · 21
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
2015 · Paul Minnis, Rosemary Kane, et al. · 13
P242 Pirfenidone As A Bridge To Lung Transplantation In Patients With Progressive Ipf
2014 · P. Riddell, P. Minnis, et al. · Thorax · 8
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5
Reflux in idiopathic pulmonary fibrosis: Table 1,
2015 · P. Minnis, K. Henry, et al. · QJM · 4
Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry
2025 · Ahmed Fahim, Maria Loughenbury, et al. · BMJ Open Respiratory Research · 2
PDF
A National Evaluation of Intercostal Chest Drain Removal Strategies
2025 · Niki Veale, Anthony W. Martinelli, et al. · CHEST Journal · 1
Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease
2023 · Giles Dixon, Samuel Hague, et al. · 1
A rare cause of cystic lung disease – Birt-Hogg-Dubé syndrome
2016 · P. Minnis, P. Riddell, et al. · Respiratory Medicine Case Reports · 1
PDF
S120 Serum MicroRNA profiles in IPF patients – biomarkers or potential therapeutic targets?
2015 · P Minnis, R Kane, et al. · Thorax · 1
PDF
Predicting progression of RA-ILD using anti-CCP
2015 · Paul Minnis, Karol Henry, et al. · 1
S16 Impact of hospitalisation in ILD subtypes and predictors of outcome
2025 · E Moran, M Ashfaq, et al.
P241 Differential methylation analysis in fibrotic versus non-fibrotic sarcoidosis
2025 · L Huajian, P Kenny, et al.
P21 Impact of treatment on quality-of-life measures in sarcoidosis
2025 · R Doherty, I Bhalwel, et al.
YACTA airway analysis in sarcoidosis
2025 · Cormac McCool, Lisa Graham, et al.
Ethnic differences in presentation and treatment of sarcoidosis from the British Thoracic Society (BTS) UK Interstitial Lung Disease (ILD) registry.
2025 · Karol Bączek, Paul Minnis, et al.
Works count: 58
Citation count: 2,301
H-index: 11
I10-index: 11
Year
Topic
Type